Has Frank Eder, MD received payments from drug or device companies?

Yes. Drug and device makers reported $46,248,527 in general payments to Frank Eder, MD across 6,915 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Eder, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Eder, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Eder, MD

Family Medicine · Binghamton, NYNPI 1528069077

Payments from drug & device makers

$46,248,527in general payments, 2019–2025

Across 6,915 payments — averaging $6688.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Modernatx, Inc.$34.4M
Pfizer$4.6M
Seqirus USA Inc$1.8M
Sanofi Pasteur Inc.$900K
Valneva Austria GmbH$788K
Bavarian Nordic A/s$623K
plus $3.2M from 54 others

$47,899in research payments, 2019–2025

Across 18 payments — averaging $2661.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Valneva Austria GmbH$46K
Novavax Inc$2K
Eli Lilly$555

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Modernatx, Inc.	3,977	$34,391,920
Pfizer	448	$4,562,735
Seqirus USA Inc	813	$1,779,455
Sanofi Pasteur Inc.	74	$900,287
Valneva Austria GmbH	48	$788,423
Bavarian Nordic A/s	42	$622,862
GSK	181	$505,676
Boehringer Ingelheim	77	$458,460
Novavax Inc	47	$448,980
Johnson & Johnson	53	$405,769
Janssen Research & Development, LLC	96	$348,071
AstraZeneca	57	$196,660
Novartis	46	$194,721
Eli Lilly	17	$182,523
Currax Pharmaceuticals LLC	28	$146,398
Regeneron	32	$66,089
AbbVie(2 entities)	278	$43,334
Chiesi USA, Inc.	15	$35,118
BD	3	$35,012
Amgen	47	$34,090
Boehringer Ingelheim International GmbH	114	$22,198
Cue Health Inc.	2	$18,555
Organon	5	$15,075
Esperion Therapeutics, Inc.	22	$13,550
Astrazeneca UK Limited	2	$9,967
Adaptive Biotechnologies Corporation	1	$9,118
Boehringer Ingelheim Pharma GmbH & Co.kg	1	$6,677
Novo Nordisk	143	$2,119
Lilly USA, LLC	27	$526
Astellas Pharma US Inc	22	$480
Exact Sciences	12	$390
Abbott	23	$388
Takeda Pharmaceuticals U.S.A., Inc.	23	$298
Edwards Lifesciences	2	$284
Merck	14	$226
Optinose US, Inc.	12	$224
Antares Pharma, Inc.	11	$191
Sunovion Pharmaceuticals Inc.	18	$178
Amarin Pharma, Inc.	9	$138
Phathom Pharmaceuticals, Inc.	7	$122
Verona Pharma, Inc.	5	$114
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$110
Grifols USA, LLC	3	$108
Teva Pharmaceuticals USA, Inc.	6	$84
E.r. Squibb & Sons, L.L.C.	5	$77
Corcept Therapeutics	4	$77
Alkermes, Inc.	3	$60
Biohaven Pharmaceutical Holding Company Ltd.	3	$58
Axsome Therapeutics, Inc.	3	$57
Otsuka America Pharmaceutical, Inc.	3	$55
Corium, LLC	3	$55
Bayer	3	$49
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$42
Impel Pharmaceuticals Inc.	2	$38
Xeris Pharmaceuticals, Inc.	2	$33
Dynavax Technologies Corporation	2	$32
Halozyme Inc	1	$20
EMD Serono, Inc.	1	$19
Collegium Pharmaceutical, Inc.	1	$18
Ironwood Pharmaceuticals, Inc	1	$18

How this compares

$46,248,527 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York →

Medicare billing

Part B allowed, 2024

$54,590

Medicare patients

224

Services billed

712

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Binghamton

Sanjiv PatelBinghamton$41K
Matthew DavisRochester$76.6M
Suchet PatelEndwell$23.3M
James WildGowanda$2.2M
Michael FedericoEndwell$1.4M
Donald BrautigamWestfield$1.3M
Kimberly DesantisEndwell$1.1M
Michael TugetmanHartsdale$1M
Richard RuhOrchard Park$769K
Eric LorraineEndwell$740K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →